{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:03:35Z","timestamp":1794258215232,"version":"4.9.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"crossref","award":["RS-2025-00513306"],"award-info":[{"award-number":["RS-2025-00513306"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"crossref","award":["RS-2024-00449435"],"award-info":[{"award-number":["RS-2024-00449435"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03850-9","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T08:55:14Z","timestamp":1763801714000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["AI-guided design of a CXCR4-targeted core-shell nanocarrier for co-delivery of berberine\/paclitaxel in cancer therapy"],"prefix":"10.1186","volume":"23","author":[{"given":"Yeonwoo","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahil","family":"Chahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arathy","family":"Vasukutty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"J. Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Kyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansoo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,22]]},"reference":[{"key":"3850_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drudis.2006.11.008","volume":"12","author":"GR Zimmermann","year":"2007","unstructured":"Zimmermann GR, Lehar J, Keith CT. Multi-target therapeutics: when the whole is greater than the sum of the parts. Drug Discov Today. 2007;12:34\u201342.","journal-title":"Drug Discov Today"},{"key":"3850_CR2","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jddst.2017.04.019","volume":"39","author":"R Pushpalatha","year":"2017","unstructured":"Pushpalatha R, Selvamuthukumar S, Kilimozhi D. Nanocarrier mediated combination drug delivery for chemotherapy\u2013a review. J Drug Deliv Sci Technol. 2017;39:362\u201371.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3850_CR3","doi-asserted-by":"publisher","first-page":"17939","DOI":"10.1073\/pnas.1011368107","volume":"107","author":"N Kolishetti","year":"2010","unstructured":"Kolishetti N, Dhar S, Valencia PM, Lin LQ, Karnik R, Lippard SJ, et al. Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy. Proc Natl Acad Sci U S A. 2010;107:17939\u201344.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3850_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19103264","volume":"19","author":"S Gurunathan","year":"2018","unstructured":"Gurunathan S, Kang M-H, Qasim M, Kim J-H. Nanoparticle-mediated combination therapy: two-in-one approach for cancer. Int J Mol Sci. 2018;19:3264.","journal-title":"Int J Mol Sci"},{"key":"3850_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/1097-0142(197501)35:1<98::AID-CNCR2820350115>3.0.CO;2-B","volume":"35","author":"VT Devita Jr","year":"1975","unstructured":"Devita VT Jr, Young RC, Canellos GP. Combination versus single agent chemotherapy: a review of the basis for selection of drug treatment of cancer. Cancer. 1975;35:98\u2013110.","journal-title":"Cancer"},{"key":"3850_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrd2683","volume":"8","author":"J Jia","year":"2009","unstructured":"Jia J, Zhu F, Ma X, Cao ZW, Li YX, Chen YZ. Mechanisms of drug combinations: interaction and network perspectives. Nat Rev Drug Discov. 2009;8:111\u201328.","journal-title":"Nat Rev Drug Discov"},{"key":"3850_CR7","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.bcp.2012.01.008","volume":"83","author":"C-MJ Hu","year":"2012","unstructured":"Hu C-MJ, Zhang L. Nanoparticle-based combination therapy toward overcoming drug resistance in cancer. Biochem Pharmacol. 2012;83:1104\u201311.","journal-title":"Biochem Pharmacol"},{"key":"3850_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131278","volume":"10","author":"J Xu","year":"2015","unstructured":"Xu J, Jin B, Ren Z, Lou Y, Zhou Z, Yang Q, et al. Chemotherapy plus erlotinib versus chemotherapy alone for treating advanced non-small cell lung cancer: a meta-analysis. PLoS One. 2015;10:e0131278.","journal-title":"PLoS One"},{"key":"3850_CR9","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1039\/C4CC08831J","volume":"51","author":"W Xiao","year":"2015","unstructured":"Xiao W, Zeng X, Lin H, Han K, Jia H-Z, Zhang X-Z. Dual stimuli-responsive multi-drug delivery system for the individually controlled release of anti-cancer drugs. Chem Commun. 2015;51:1475\u20138.","journal-title":"Chem Commun"},{"key":"3850_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12272-013-0276-2","volume":"37","author":"G Kibria","year":"2014","unstructured":"Kibria G, Hatakeyama H, Harashima H. Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system. Arch Pharm Res. 2014;37:4\u201315.","journal-title":"Arch Pharm Res"},{"key":"3850_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmt.2023.101834","volume":"33","author":"Y Jang","year":"2023","unstructured":"Jang Y, Kim A, Moon JJ, Lee JY, Park H. Novel bioengineering strategies for drug delivery systems. Appl Mater Today. 2023;33:101834.","journal-title":"Appl Mater Today"},{"key":"3850_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","volume":"65","author":"H Maeda","year":"2000","unstructured":"Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000;65:271\u201384.","journal-title":"J Control Release"},{"key":"3850_CR13","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nrc1958","volume":"6","author":"R Duncan","year":"2006","unstructured":"Duncan R. Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer. 2006;6:688\u2013701.","journal-title":"Nat Rev Cancer"},{"key":"3850_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3109\/1061186X.2015.1051049","volume":"24","author":"P Kumari","year":"2016","unstructured":"Kumari P, Ghosh B, Biswas S. Nanocarriers for cancer-targeted drug delivery. J Drug Target. 2016;24:179\u201391.","journal-title":"J Drug Target"},{"key":"3850_CR15","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s00259-023-06547-z","volume":"51","author":"N Dreher","year":"2024","unstructured":"Dreher N, Hahner S, Fu\u00df CT, Schl\u00f6telburg W, Hartrampf PE, Serfling SE, et al. CXCR4-directed PET\/CT with [68 Ga] Ga-pentixafor in solid tumors\u2014a comprehensive analysis of imaging findings and comparison with histopathology. Eur J Nucl Med Mol Imaging. 2024;51:1383\u201394.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3850_CR16","doi-asserted-by":"publisher","first-page":"17129","DOI":"10.1021\/acsami.3c18569","volume":"16","author":"Y Jang","year":"2024","unstructured":"Jang Y, Cho YS, Kim A, Zhou X, Kim Y, Wan Z, et al. CXCR4-targeted macrophage-derived biomimetic hybrid vesicle nanoplatform for enhanced cancer therapy through codelivery of manganese and doxorubicin. ACS Appl Mater Interfaces. 2024;16:17129\u201344.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3850_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsusc.2025.162745","volume":"695","author":"Y Jang","year":"2025","unstructured":"Jang Y, Park H. CXCR4-binding peptide-functionalized M1 macrophage vesicle-coated micelles for enhanced targeting and 6BIO-mediated cancer combination therapy. Appl Surf Sci. 2025;695:162745.","journal-title":"Appl Surf Sci"},{"key":"3850_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jare.2018.06.005","volume":"15","author":"S Hossen","year":"2019","unstructured":"Hossen S, Hossain MK, Basher M, Mia M, Rahman M, Uddin MJ. Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: a review. J Adv Res. 2019;15:1\u201318.","journal-title":"J Adv Res"},{"key":"3850_CR19","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/S1734-1140(12)70901-5","volume":"64","author":"AZ Wilczewska","year":"2012","unstructured":"Wilczewska AZ, Niemirowicz K, Markiewicz KH. Car H. Nanoparticles as drug delivery systems. Pharmacol Rep. 2012;64:1020\u201337.","journal-title":"Pharmacol Rep"},{"key":"3850_CR20","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S344208","author":"Z Lin","year":"2022","unstructured":"Lin Z, Chou W-C, Cheng Y-H, He C, Monteiro-Riviere NA, Riviere JE. Predicting nanoparticle delivery to tumors using machine learning and artificial intelligence approaches. Int J Nanomedicine. 2022. https:\/\/doi.org\/10.2147\/IJN.S344208.","journal-title":"Int J Nanomedicine"},{"key":"3850_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jconrel.2023.07.040","volume":"361","author":"W-C Chou","year":"2023","unstructured":"Chou W-C, Chen Q, Yuan L, Cheng Y-H, He C, Monteiro-Riviere NA, et al. An artificial intelligence-assisted physiologically-based pharmacokinetic model to predict nanoparticle delivery to tumors in mice. J Control Release. 2023;361:53\u201363.","journal-title":"J Control Release"},{"key":"3850_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ijpharm.2012.09.008","volume":"453","author":"W Xu","year":"2013","unstructured":"Xu W, Riikonen J, Lehto V-P. Mesoporous systems for poorly soluble drugs. Int J Pharm. 2013;453:181\u201397.","journal-title":"Int J Pharm"},{"key":"3850_CR23","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1039\/C0CC02923H","volume":"47","author":"Y-S Lin","year":"2011","unstructured":"Lin Y-S, Abadeer N, Haynes CL. Stability of small mesoporous silica nanoparticles in biological media. Chem Commun. 2011;47:532\u20134.","journal-title":"Chem Commun"},{"key":"3850_CR24","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1021\/ja710193c","volume":"130","author":"KM Taylor","year":"2008","unstructured":"Taylor KM, Kim JS, Rieter WJ, An H, Lin W, Lin W. Mesoporous silica nanospheres as highly efficient MRI contrast agents. J Am Chem Soc. 2008;130:2154\u20135.","journal-title":"J Am Chem Soc"},{"key":"3850_CR25","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/adfm.200800753","volume":"19","author":"CH Lee","year":"2009","unstructured":"Lee CH, Cheng SH, Wang YJ, Chen YC, Chen NT, Souris J, et al. Near-infrared mesoporous silica nanoparticles for optical imaging: characterization and in vivo biodistribution. Adv Funct Mater. 2009;19:215\u201322.","journal-title":"Adv Funct Mater"},{"key":"3850_CR26","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/smll.200900005","volume":"5","author":"F Lu","year":"2009","unstructured":"Lu F, Wu SH, Hung Y, Mou CY. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small. 2009;5:1408\u201313.","journal-title":"Small"},{"key":"3850_CR27","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1002\/smll.200900923","volume":"5","author":"Q He","year":"2009","unstructured":"He Q, Zhang Z, Gao Y, Shi J, Li Y. Intracellular localization and cytotoxicity of spherical mesoporous silica nano- and microparticles. Small. 2009;5:2722\u20139.","journal-title":"Small"},{"key":"3850_CR28","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1039\/c0jm03851b","volume":"21","author":"Q He","year":"2011","unstructured":"He Q, Shi J. Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility. J Mater Chem. 2011;21:5845\u201355.","journal-title":"J Mater Chem"},{"key":"3850_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10040283","volume":"10","author":"AK Meka","year":"2018","unstructured":"Meka AK, Jenkins LJ, D\u00e0valos-Salas M, Pujara N, Wong KY, Kumeria T, et al. Enhanced solubility, permeability and anticancer activity of Vorinostat using tailored mesoporous silica nanoparticles. Pharmaceutics. 2018;10:283.","journal-title":"Pharmaceutics"},{"key":"3850_CR30","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1021\/la052797j","volume":"22","author":"RP Bagwe","year":"2006","unstructured":"Bagwe RP, Hilliard LR, Tan W. Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding. Langmuir. 2006;22:4357\u201362.","journal-title":"Langmuir"},{"key":"3850_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jlumin.2005.04.008","volume":"117","author":"S Santra","year":"2006","unstructured":"Santra S, Liesenfeld B, Bertolino C, Dutta D, Cao Z, Tan W, et al. Fluorescence lifetime measurements to determine the core\u2013shell nanostructure of FITC-doped silica nanoparticles: an optical approach to evaluate nanoparticle photostability. J Lumin. 2006;117:75\u201382.","journal-title":"J Lumin"},{"key":"3850_CR32","doi-asserted-by":"publisher","first-page":"24084","DOI":"10.1039\/C8RA03607A","volume":"8","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Wang J, Zhang H, Liu D, Ming L, Liu L, et al. The anticancer efficacy of Paclitaxel liposomes modified with low-toxicity hydrophobic cell-penetrating peptides in breast cancer: an in vitro and in vivo evaluation. RSC Adv. 2018;8:24084\u201393.","journal-title":"RSC Adv"},{"key":"3850_CR33","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2217\/nnm.13.118","volume":"8","author":"PP Deshpande","year":"2013","unstructured":"Deshpande PP, Biswas S, Torchilin VP. Current trends in the use of liposomes for tumor targeting. Nanomedicine. 2013;8:1509\u201328.","journal-title":"Nanomedicine"},{"key":"3850_CR34","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1093\/jnci\/djh314","volume":"96","author":"AS Derycke","year":"2004","unstructured":"Derycke AS, Kamuhabwa A, Gijsens A, Roskams T, De Vos D, Kasran A, Huwyler J, Missiaen L, de Witte PA. Transferrin-conjugated liposome targeting of photosensitizer AlPcS 4 to rat bladder carcinoma cells. J Natl Cancer Inst. 2004;96:1620\u201330.","journal-title":"J Natl Cancer Inst"},{"key":"3850_CR35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.tibtech.2013.09.007","volume":"32","author":"GT Noble","year":"2014","unstructured":"Noble GT, Stefanick JF, Ashley JD, Kiziltepe T, Bilgicer B. Ligand-targeted liposome design: challenges and fundamental considerations. Trends Biotechnol. 2014;32:32\u201345.","journal-title":"Trends Biotechnol"},{"key":"3850_CR36","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1016\/j.bbamcr.2015.05.012","volume":"1853","author":"Y-H Su","year":"2015","unstructured":"Su Y-H, Tang W-C, Cheng Y-W, Sia P, Huang C-C, Lee Y-C, et al. Targeting of multiple oncogenic signaling pathways by Hsp90 inhibitor alone or in combination with berberine for treatment of colorectal cancer. Biochimica et Biophysica Acta (BBA). 2015;1853:2261\u201372.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"3850_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27185889","volume":"27","author":"SA Almatroodi","year":"2022","unstructured":"Almatroodi SA, Alsahli MA, Rahmani AH. Berberine: an important emphasis on its anticancer effects through modulation of various cell signaling pathways. Molecules. 2022;27:5889.","journal-title":"Molecules"},{"key":"3850_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-019-5791-1","volume":"19","author":"J Xu","year":"2019","unstructured":"Xu J, Long Y, Ni L, Yuan X, Yu N, Wu R, et al. Anticancer effect of berberine based on experimental animal models of various cancers: a systematic review and meta-analysis. BMC Cancer. 2019;19:1\u201320.","journal-title":"BMC Cancer"},{"key":"3850_CR39","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S104729","author":"H Liu","year":"2016","unstructured":"Liu H, Huang C, Wu L, Wen B. Effect of evodiamine and berberine on miR-429 as an oncogene in human colorectal cancer. Onco Targets Ther. 2016. https:\/\/doi.org\/10.2147\/OTT.S104729.","journal-title":"Onco Targets Ther"},{"key":"3850_CR40","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.bbrc.2018.05.063","volume":"501","author":"S Kim","year":"2018","unstructured":"Kim S, Lee SY, Cho H-J. Berberine and zinc oxide-based nanoparticles for the chemo-photothermal therapy of lung adenocarcinoma. Biochem Biophys Res Commun. 2018;501:765\u201370.","journal-title":"Biochem Biophys Res Commun"},{"key":"3850_CR41","doi-asserted-by":"publisher","DOI":"10.4103\/1008-682X.169997","volume":"18","author":"Y Tian","year":"2016","unstructured":"Tian Y, Zhao L, Wang Y, Zhang H, Xu D, Zhao X, et al. Berberine inhibits androgen synthesis by interaction with aldo-keto reductase 1C3 in 22Rv1 prostate cancer cells. Asian J Androl. 2016;18:607.","journal-title":"Asian J Androl"},{"key":"3850_CR42","first-page":"292","volume":"41","author":"K Wu","year":"2012","unstructured":"Wu K, Yang Q, Mu Y, Zhou L, Liu Y, Zhou Q, He B. Berberine inhibits the proliferation of colon cancer cells by inactivating Wnt\/\u03b2-catenin signaling. Int J Oncol. 2012;41:292\u20138.","journal-title":"Int J Oncol"},{"key":"3850_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.886996","volume":"9","author":"X Jiang","year":"2022","unstructured":"Jiang X, Jiang Z, Jiang M, Sun Y. Berberine as a potential agent for the treatment of colorectal cancer. Front Med. 2022;9:886996.","journal-title":"Front Med"},{"key":"3850_CR44","doi-asserted-by":"crossref","unstructured":"Ge X, Lee Y-T, Yeh S-J. MD-Syn: synergistic drug combination prediction based on the multidimensional feature fusion method and attention mechanisms.\u00a0arXiv:250107884 [Preprint]. 2025.","DOI":"10.3389\/fphar.2025.1564339"},{"key":"3850_CR45","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.colsurfb.2012.11.031","volume":"104","author":"K Smitha","year":"2013","unstructured":"Smitha K, Anitha A, Furuike T, Tamura H, Nair SV, Jayakumar RJC, Biointerfaces SB. In vitro evaluation of Paclitaxel loaded amorphous Chitin nanoparticles for colon cancer drug delivery. Colloids Surf B. 2013;104:245\u201353.","journal-title":"Colloids Surf B"},{"key":"3850_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/biom9120789","volume":"9","author":"TM Abu Samaan","year":"2019","unstructured":"Abu Samaan TM, Samec M, Liskova A, Kubatka P, B\u00fcsselberg D. Paclitaxel\u2019s mechanistic and clinical effects on breast cancer. Biomolecules. 2019;9:789.","journal-title":"Biomolecules"},{"key":"3850_CR47","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1056\/NEJMoa052985","volume":"354","author":"DK Armstrong","year":"2006","unstructured":"Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, Copeland LJ, Walker JL. Burger rajnejom: intraperitoneal cisplatin and Paclitaxel in ovarian cancer. N Engl J Med. 2006;354:34\u201343.","journal-title":"N Engl J Med"},{"key":"3850_CR48","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.phrs.2019.01.013","volume":"141","author":"J Jim\u00e9nez-L\u00f3pez","year":"2019","unstructured":"Jim\u00e9nez-L\u00f3pez J, El-Hammadi MM, Ortiz R, Cayero-Otero MD, Cabeza L, Perazzoli G, et al. A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer. Pharmacol Res. 2019;141:451\u201365.","journal-title":"Pharmacol Res"},{"key":"3850_CR49","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S122859","author":"J Sun","year":"2017","unstructured":"Sun J, Jiang L, Lin Y, Gerhard EM, Jiang X, Li L, et al. Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides. Int J Nanomedicine. 2017. https:\/\/doi.org\/10.2147\/IJN.S122859.","journal-title":"Int J Nanomedicine"},{"key":"3850_CR50","doi-asserted-by":"publisher","first-page":"12351","DOI":"10.1021\/acsami.7b18437","volume":"10","author":"P Ma","year":"2018","unstructured":"Ma P, Chen J, Bi X, Li Z, Gao X, Li H, et al. Aam, interfaces: overcoming multidrug resistance through the GLUT1-mediated and enzyme-triggered mitochondrial targeting conjugate with redox-sensitive Paclitaxel release. ACS Appl Mater Interfaces. 2018;10:12351\u201363.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3850_CR51","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ctrv.2012.02.011","volume":"38","author":"S Murray","year":"2012","unstructured":"Murray S, Briasoulis E, Linardou H, Bafaloukos D, Papadimitriou C. Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circumvention strategies. Cancer Treat Rev. 2012;38:890\u2013903.","journal-title":"Cancer Treat Rev"},{"key":"3850_CR52","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jconrel.2019.12.011","volume":"318","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Ji Y. Mitochondria-targeting nanomedicine self-assembled from GSH-responsive paclitaxel-ss-berberine conjugate for synergetic cancer treatment with enhanced cytotoxicity. J Control Release. 2020;318:38\u201349.","journal-title":"J Control Release"},{"key":"3850_CR53","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.lfs.2018.04.050","volume":"208","author":"C Xu","year":"2018","unstructured":"Xu C, Zheng L, Li D, Chen G, Gu J, Chen J, et al. CXCR4 overexpression is correlated with poor prognosis in colorectal cancer. Life Sci. 2018;208:333\u201340.","journal-title":"Life Sci"},{"key":"3850_CR54","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1002\/ijc.24956","volume":"126","author":"O Kollmar","year":"2010","unstructured":"Kollmar O, Rupertus K, Scheuer C, Nickels RM, Haberl GC, Tilton B, et al. CXCR4 and CXCR7 regulate angiogenesis and CT26. WT tumor growth independent from SDF-1. Int J Cancer. 2010;126:1302\u201315.","journal-title":"Int J Cancer"},{"key":"3850_CR55","doi-asserted-by":"publisher","first-page":"W419","DOI":"10.1093\/nar\/gkv456","volume":"43","author":"M Kurcinski","year":"2015","unstructured":"Kurcinski M, Jamroz M, Blaszczyk M, Kolinski A, Kmiecik S. CABS-dock web server for the flexible Docking of peptides to proteins without prior knowledge of the binding site. Nucleic Acids Res. 2015;43:W419\u201324.","journal-title":"Nucleic Acids Res"},{"key":"3850_CR56","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.yexcr.2005.07.006","volume":"310","author":"S Brand","year":"2005","unstructured":"Brand S, Dambacher J, Beigel F, Olszak T, Diebold J, Otte J-M, et al. Eichhorst stjecr: CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation. Exp Cell Res. 2005;310:117\u201330.","journal-title":"Exp Cell Res"},{"key":"3850_CR57","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.3892\/ijmm.2012.1141","volume":"30","author":"H-N Shin","year":"2012","unstructured":"Shin H-N, Moon H-H, Ku J-L. Stromal cell-derived factor-1\u03b1 and macrophage migration-inhibitory factor induce metastatic behavior in CXCR4-expressing colon cancer cells. Int J Mol Med. 2012;30:1537\u201343.","journal-title":"Int J Mol Med"},{"key":"3850_CR58","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/jgm.1366","volume":"11","author":"A Egorova","year":"2009","unstructured":"Egorova A, Kiselev A, Hakli M, Ruponen M, Baranov V, Urtti A. Chemokine-derived peptides as carriers for gene delivery to CXCR4 expressing cells. J Gene Med. 2009;11:772\u201381.","journal-title":"J Gene Med"},{"key":"3850_CR59","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1016\/j.matpr.2015.07.098","volume":"2","author":"R Dubey","year":"2015","unstructured":"Dubey R, Rajesh Y, More M. Synthesis and characterization of SiO2 nanoparticles via sol-gel method for industrial applications. Mater Today Proc. 2015;2:3575\u20139.","journal-title":"Mater Today Proc"},{"key":"3850_CR60","doi-asserted-by":"publisher","first-page":"7673","DOI":"10.1016\/j.ceramint.2019.01.067","volume":"45","author":"X Jiang","year":"2019","unstructured":"Jiang X, Tang X, Tang L, Zhang B, Mao H. Synthesis and formation mechanism of amorphous silica particles via sol\u2013gel process with tetraethylorthosilicate. Ceram Int. 2019;45:7673\u201380.","journal-title":"Ceram Int"},{"key":"3850_CR61","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.1039\/C9BM00822E","volume":"7","author":"Z Chaudhary","year":"2019","unstructured":"Chaudhary Z, Khan GM, Abeer MM, Pujara N, Tse BW-C, McGuckin MA, et al. Efficient photoacoustic imaging using indocyanine green (ICG) loaded functionalized mesoporous silica nanoparticles. Biomater Sci. 2019;7:5002\u201315.","journal-title":"Biomater Sci"},{"key":"3850_CR62","doi-asserted-by":"publisher","first-page":"7567","DOI":"10.1021\/ja902039y","volume":"131","author":"J Liu","year":"2009","unstructured":"Liu J, Jiang X, Ashley C, Brinker C. Electrostatically mediated liposome fusion and lipid exchange with a nanoparticle-supported bilayer for control of surface charge, drug containment, and delivery. J Am Chem Soc. 2009;131:7567\u20139.","journal-title":"J Am Chem Soc"},{"key":"3850_CR63","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbad419","author":"J Dong","year":"2023","unstructured":"Dong J, Wu Z, Xu H, Ouyang D. FormulationAI: a novel web-based platform for drug formulation design driven by artificial intelligence. Brief Bioinform. 2023. https:\/\/doi.org\/10.1093\/bib\/bbad419.","journal-title":"Brief Bioinform"},{"key":"3850_CR64","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/35065016","volume":"410","author":"A M\u00fcller","year":"2001","unstructured":"M\u00fcller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410:50\u20136.","journal-title":"Nature"},{"key":"3850_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-02013-y","volume":"21","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang Q, Wang X, Yao P, Dai Q, Qi X, et al. Docetaxel-loaded pH\/ROS dual-responsive nanoparticles with self-supplied ROS for inhibiting metastasis and enhancing immunotherapy of breast cancer. J Nanobiotechnol. 2023;21:286.","journal-title":"J Nanobiotechnol"},{"key":"3850_CR66","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1002\/smll.200700005","volume":"3","author":"J Lu","year":"2007","unstructured":"Lu J, Liong M, Zink JI, Tamanoi F. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. small. 2007;3:1341\u20136.","journal-title":"small"},{"key":"3850_CR67","doi-asserted-by":"publisher","first-page":"14792","DOI":"10.1021\/ja0645943","volume":"128","author":"I Slowing","year":"2006","unstructured":"Slowing I, Trewyn BG, Lin VS-Y. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. J Am Chem Soc. 2006;128:14792\u20133.","journal-title":"J Am Chem Soc"},{"key":"3850_CR68","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.1021\/cm0210041","volume":"15","author":"S Huh","year":"2003","unstructured":"Huh S, Wiench JW, Yoo J-C, Pruski M, Lin VS-Y. Organic functionalization and morphology control of mesoporous silicas via a co-condensation synthesis method. Chem Mater. 2003;15:4247\u201356.","journal-title":"Chem Mater"},{"key":"3850_CR69","doi-asserted-by":"crossref","unstructured":"Hansen CB, Kao GY, Moase EH, Zalipsky S. Allen TM. Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1995;1239:133\u201344.","DOI":"10.1016\/0005-2736(95)00138-S"},{"key":"3850_CR70","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3109\/21691401.2014.951722","volume":"44","author":"Y Xu","year":"2016","unstructured":"Xu Y, Meng H. Paclitaxel-loaded stealth liposomes: development, characterization, pharmacokinetics, and biodistribution. Artif Cells Nanomed Biotechnol. 2016;44:350\u20135.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"3850_CR71","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.colsurfb.2015.02.040","volume":"128","author":"HB Ruttala","year":"2015","unstructured":"Ruttala HB, Ko YT. Liposomal co-delivery of Curcumin and albumin\/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy. Colloids Surf B Biointerfaces. 2015;128:419\u201326.","journal-title":"Colloids Surf B Biointerfaces"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03850-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03850-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03850-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T20:02:20Z","timestamp":1766088140000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-025-03850-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,22]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3850"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03850-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7307122\/v1","asserted-by":"object"}]},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,22]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were performed in accordance with the Institutional Animal Care and Use Committee Chonnam National University (CNU IACUC-H-2024-23), South Korea.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"773"}}